BASIC// DISCOVERY

SOLVING the PUZZLE
of FIBROTIC DISEASES
UP TO 40 PERCENT OF DISEASE MORTALITY IN DEVELOPED
countries results from fibrotic diseases, a family
of conditions where the build-up of scarlike tissue interferes with the body’s normal
function. These conditions can be systemic
(such as systemic sclerosis and scleroderma) or
affect individual organs such as the lung, liver,
kidney, heart or eye. Because the mechanisms
underlying these conditions are poorly understood
and treatments are few, Jefferson has made a
major commitment to basic and translational
research on a broad range of fibrotic diseases.
Pulmonary Fibrosis (PF) causes progressive,
potentially fatal scarring of the lung. PF results, in
part, from the inability of aging lung epithelial cells to
regenerate after injury. This may be because aging
cells do not direct nutrients to areas at greatest
need after injury. Ross Summer, MD, professor
of medicine, has been working to determine the
interconnections between cellular metabolism and
injury repair. His studies on young cells’ metabolic
adaptation to injury offer clues on how aging
compromises the repair process—and suggests
therapeutic approaches. For example, Dr. Summer
has found that blocking lipid synthesis, alone, can
cause fibrotic scarring in animal models; and, in
counterpoint, has demonstrated that increased
lipid production could reduce fibrosis-caused lung
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scarring significantly. He is now working to identify
and test molecules that could have therapeutic
effect by enhancing or protecting lipid synthesis.
Because scars that form in all injured tissues and
organs are comprised primarily of collagen-rich
fibrils, Andrzej Fertala, PhD, professor of orthopaedic
surgery, has been developing an antibody to block
an early step in fibril formation. Having shown the
antibody to be effective at blocking fibril production
in a mouse model of pulmonary fibrosis and a rabbit
model of arthrofibrosis, Dr. Fertala is now fine-tuning
it to create a therapeutic-grade biologic. Teaming
with orthopaedic surgeons, Dr. Fertala’s group is also
testing the possibility of employing the anti-fibrotic
antibody to block fibrosis of injured peripheral nerves,
which hampers the nerve regeneration process.
Cataract surgery often results in a fibrotic disease
known as Posterior Capsule Opacification (PCO),
which can lead to loss of vision. Sue Menko, PhD,
professor of pathology, anatomy and cell biology,
developed a chick embryo model of PCO and uses
it to identify cell-signaling pathways involved in
fibrosis and to study other mechanisms of wound
healing and fibrosis. These studies have led to
a series of significant discoveries. For example,
she and Janice Walker, PhD, assistant professor
of pathology, anatomy and cell biology, found

Image from Sue Menko, PhD, and Janice
Walker, PhD: A 3D image of fibrotic cells
associated with the lens fibrotic disease
Posterior Capsule Opacification (PCO).

that the lens harbors a resident population of
vimentin-rich mesenchymal cells that migrate
to the wound edge, where they play a role in
wound repair. Spurred by their encounter with a
microenvironment of increased rigidly, these cells
differentiate to myofibroblasts—the principal cell
type associated with fibrosis. Subsequently, the
researchers found that injury spurs the release of
the protein vimentin, which binds to mesenchymal
cells at the wound and helps signal the shift
into a myofibroblast and the development of
fibrosis. These findings may provide novel targets
for development of new treatments for PCO.
Until very recently, the lens had been considered
not susceptible to the immune processes normally
associated with wound repair; most investigators
assumed that immune cells played no role in PCO.
However, using a lens-specific knockout mouse
model, Dr. Menko’s team found that degeneration
of the lens activates an immune response both
to the lens and throughout the eye (including
cornea, vitreous humor and retina) that contributes
to development of fibrosis associated with
cataractogenesis. Additionally, they demonstrated
that the lens is indirectly connected to the lymphatic
system, providing a potential mechanism for the
immune surveillance. Their findings have broad
implications for understanding disease and injuryrepair processes throughout the eye.
Children with a grave skin disorder known as
butterfly disease (epidermolysis bullosa or EB)
develop severe and chronic blisters and fibrosis
within their connective tissues. The condition
leads to club-like appendages where the skin
grows over the fingers or toes. Andrew South,
PhD, associate professor of dermatology and
cutaneous biology, has shown that fibrosis also
leads to an aggressive, often fatal, form of skin
cancer in butterfly children. Recently, Dr. South
and colleagues pinpointed how fibrosis develops
in butterfly children—and demonstrated that a
specific molecule interferes with the process and
reduces fibrosis in a tissue-engineered model. Now
his team is working to develop the molecule as a
potential therapy for the debilitating condition. 
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